| (-)-epigallocatechin 3-gallate | multiple interactions | ISO | RGD:1323522 | 6480464 | [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of NRIP1 mRNA | CTD | PMID:22079256 |
| 1-naphthol | increases expression | ISO | RGD:1323522 | 6480464 | 1-naphthol results in increased expression of NRIP1 mRNA | CTD | PMID:22989670 |
| 17beta-estradiol | affects expression | ISO | RGD:1323522 | 6480464 | Estradiol affects the expression of NRIP1 mRNA | CTD | PMID:14699072 |
| 17beta-estradiol | multiple interactions | ISO | RGD:1323522 | 6480464 | [Estradiol binds to ESR2 protein] which results in increased expression of NRIP1 mRNA | CTD | PMID:20404318 |
| 17beta-estradiol | increases expression | ISO | RGD:1323522 | 6480464 | Estradiol results in increased expression of NRIP1 mRNA | CTD | PMID:15757668 more ... |
| 17beta-estradiol | increases expression | ISO | RGD:1323522 | 6480464 | Estradiol results in increased expression of NRIP1 mRNA | CTD | PMID:15757668 more ... |
| 17beta-estradiol | affects response to substance | ISO | RGD:1323522 | 6480464 | NRIP1 protein affects the susceptibility to Estradiol | CTD | PMID:22071320 |
| 17beta-estradiol | multiple interactions | ISO | RGD:1323522 | 6480464 | AHR protein affects the reaction [Estradiol promotes the reaction [NRIP1 protein binds to HSPB8 promoter]]; more ... | CTD | PMID:22071320 |
| 17beta-estradiol | increases expression | ISO | RGD:1323522 | 6480464 | Estradiol results in increased expression of NRIP1 mRNA | CTD | PMID:15757668 more ... |
| 17beta-estradiol | increases expression | ISO | RGD:1323522 | 6480464 | Estradiol results in increased expression of NRIP1 mRNA | CTD | PMID:15757668 more ... |
| 17beta-estradiol | increases expression | ISO | RGD:1323522 | 6480464 | Estradiol results in increased expression of NRIP1 mRNA | CTD | PMID:16029874 more ... |
| 17beta-estradiol | multiple interactions | ISO | RGD:1311850 | 6480464 | [Estradiol co-treated with ormeloxifene] promotes the reaction [NRIP1 protein binds to ESR1 protein] | CTD | PMID:19460436 |
| 17beta-estradiol | increases expression | ISO | RGD:1323522 | 6480464 | Estradiol results in increased expression of NRIP1 mRNA | CTD | PMID:17555868 more ... |
| 17beta-estradiol | affects expression | EXP | | 6480464 | Estradiol affects the expression of NRIP1 mRNA | CTD | PMID:15598610 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:1323522 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of NRIP1 mRNA | CTD | PMID:17555868 |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | RGD:1311850 | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of NRIP1 mRNA | CTD | PMID:23238561 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of NRIP1 mRNA | CTD | PMID:23238561 |
| 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | RGD:1323522 | 6480464 | Tetrachlorodibenzodioxin affects the expression of NRIP1 mRNA | CTD | PMID:22574217 |
| 2,3,7,8-tetrachlorodibenzodioxine | affects expression | EXP | | 6480464 | Tetrachlorodibenzodioxin affects the expression of NRIP1 mRNA | CTD | PMID:18691609 PMID:21570461 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:1323522 | 6480464 | [Tetrachlorodibenzodioxin promotes the reaction [NRIP1 protein binds to CYP1A1 promoter]] which results in increased expression of CYP1A1 mRNA; more ... | CTD | PMID:22071320 |
| 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | RGD:1311850 | 6480464 | Tetrachlorodibenzodioxin affects the expression of NRIP1 mRNA | CTD | PMID:22298810 |
| 2,3,7,8-tetrachlorodibenzodioxine | affects expression | EXP | | 6480464 | Tetrachlorodibenzodioxin affects the expression of NRIP1 mRNA | CTD | PMID:18691609 |
| 3,4-methylenedioxymethamphetamine | increases expression | EXP | | 6480464 | N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of NRIP1 mRNA | CTD | PMID:20188158 |
| 4,4'-diaminodiphenylmethane | decreases expression | EXP | | 6480464 | 4,4'-diaminodiphenylmethane results in decreased expression of NRIP1 mRNA | CTD | PMID:18648102 |
| 4-\{[(5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthalen-2-yl)carbonyl]amino\}benzoic acid | increases expression | ISO | RGD:1323522 | 6480464 | Am 580 results in increased expression of NRIP1 mRNA | CTD | PMID:16982809 |
| 4-hydroxyphenyl retinamide | increases expression | ISO | RGD:1323522 | 6480464 | Fenretinide results in increased expression of NRIP1 mRNA | CTD | PMID:15958647 |
| 5-fluorouracil | multiple interactions | ISO | RGD:1323522 | 6480464 | [Fluorouracil co-treated with irinotecan] results in increased expression of NRIP1 mRNA | CTD | PMID:16391804 |
| 5-fluorouracil | decreases expression | ISO | RGD:1323522 | 6480464 | Fluorouracil results in decreased expression of NRIP1 mRNA | CTD | PMID:16510598 |
| 9-phenanthrol | increases expression | ISO | RGD:1323522 | 6480464 | 9-phenanthrol results in increased expression of NRIP1 mRNA | CTD | PMID:22989670 |
| acetazolamide | increases expression | EXP | | 6480464 | Acetazolamide results in increased expression of NRIP1 mRNA | CTD | PMID:19274763 |
| afimoxifene | multiple interactions | ISO | RGD:1323522 | 6480464 | 4-hydroxytamoxifen inhibits the reaction [Estrogens results in increased expression of NRIP1 mRNA] | CTD | PMID:21233418 |
| all-trans-retinoic acid | increases expression | ISO | RGD:1323522 | 6480464 | Tretinoin results in increased expression of NRIP1 mRNA | CTD | PMID:16249480 |
| all-trans-retinoic acid | increases expression | ISO | RGD:1323522 | 6480464 | Tretinoin results in increased expression of NRIP1 mRNA | CTD | PMID:21934132 PMID:16249480 |
| all-trans-retinoic acid | increases expression | ISO | RGD:1323522 | 6480464 | Tretinoin results in increased expression of NRIP1 mRNA | CTD | PMID:16249480 PMID:21934132 |
| all-trans-retinoic acid | increases expression | EXP | | 6480464 | Tretinoin results in increased expression of NRIP1 mRNA | CTD | PMID:16604517 |
| all-trans-retinoic acid | multiple interactions | EXP | | 6480464 | Tretinoin affects the reaction [NRIP1 protein binds to NR2C1 promoter] | CTD | PMID:17389641 |
| benzo[a]pyrene | multiple interactions | EXP | | 6480464 | [Benzo(a)pyrene co-treated with XPA gene mutant form co-treated with TRP53 gene mutant form] results in decreased expression of NRIP1 mRNA | CTD | PMID:21715664 |
| bisphenol A | increases expression | ISO | RGD:1323522 | 6480464 | bisphenol A results in increased expression of NRIP1 mRNA | CTD | PMID:19371625 |
| calcitriol | increases expression | ISO | RGD:1323522 | 6480464 | Calcitriol results in increased expression of NRIP1 mRNA | CTD | PMID:16002434 |
| choline | multiple interactions | EXP | | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of NRIP1 gene | CTD | PMID:20938992 |
| crocidolite asbestos | affects expression | ISO | RGD:1323522 | 6480464 | Asbestos, Crocidolite affects the expression of NRIP1 mRNA | CTD | PMID:17331233 |
| daidzein | increases expression | ISO | RGD:1323522 | 6480464 | daidzein results in increased expression of NRIP1 mRNA | CTD | PMID:15757668 |
| diethylstilbestrol | increases expression | ISO | RGD:1323522 | 6480464 | Diethylstilbestrol results in increased expression of NRIP1 mRNA | CTD | PMID:19371625 |
| etoposide | affects response to substance | ISO | RGD:1323522 | 6480464 | NRIP1 protein affects the susceptibility to Etoposide | CTD | PMID:16217747 |
| folic acid | multiple interactions | EXP | | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of NRIP1 gene | CTD | PMID:20938992 |
| formaldehyde | decreases expression | ISO | RGD:1323522 | 6480464 | Formaldehyde results in decreased expression of NRIP1 mRNA | CTD | PMID:20655997 |
| genistein | increases expression | ISO | RGD:1323522 | 6480464 | Genistein results in increased expression of NRIP1 mRNA | CTD | PMID:19371625 PMID:15757668 |
| genistein | increases expression | ISO | RGD:1323522 | 6480464 | Genistein results in increased expression of NRIP1 mRNA | CTD | PMID:15757668 more ... |
| genistein | increases expression | ISO | RGD:1323522 | 6480464 | Genistein results in increased expression of NRIP1 mRNA | CTD | PMID:15757668 PMID:19371625 |
| L-methionine | multiple interactions | EXP | | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of NRIP1 gene | CTD | PMID:20938992 |
| lead diacetate | affects expression | EXP | | 6480464 | lead acetate affects the expression of NRIP1 mRNA | CTD | PMID:21829687 |
| mitomycin C | affects response to substance | ISO | RGD:1323522 | 6480464 | NRIP1 protein affects the susceptibility to Mitomycin | CTD | PMID:16217747 |
| mitoxantrone | affects response to substance | ISO | RGD:1323522 | 6480464 | NRIP1 protein affects the susceptibility to Mitoxantrone | CTD | PMID:16217747 |
| N-nitrosodiethylamine | decreases expression | ISO | RGD:1323522 | 6480464 | Diethylnitrosamine results in decreased expression of NRIP1 mRNA | CTD | PMID:21527772 |
| paracetamol | affects expression | EXP | | 6480464 | Acetaminophen affects the expression of NRIP1 mRNA | CTD | PMID:17562736 |
| phenobarbital | affects expression | EXP | | 6480464 | Phenobarbital affects the expression of NRIP1 mRNA | CTD | PMID:23091169 |
| pirinixic acid | increases expression | EXP | | 6480464 | pirinixic acid results in increased expression of NRIP1 mRNA | CTD | PMID:18301758 |
| piroxicam | decreases expression | ISO | RGD:1323522 | 6480464 | Piroxicam results in decreased expression of NRIP1 mRNA | CTD | PMID:21858171 |
| pyridoxal 5'-phosphate | multiple interactions | EXP | | 6480464 | Pyridoxal Phosphate binds to and results in increased activity of NRIP1 protein | CTD | PMID:17277785 |
| resveratrol | decreases expression | EXP | | 6480464 | resveratrol results in decreased expression of NRIP1 mRNA | CTD | PMID:21109418 |
| rosiglitazone | increases expression | ISO | RGD:1323522 | 6480464 | rosiglitazone results in increased expression of NRIP1 mRNA | CTD | PMID:16982809 |
| rosiglitazone | affects expression | EXP | | 6480464 | rosiglitazone affects the expression of NRIP1 mRNA | CTD | PMID:22013433 |
| succimer | multiple interactions | EXP | | 6480464 | [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of NRIP1 mRNA | CTD | PMID:21641980 |
| trans-resveratrol | decreases expression | EXP | | 6480464 | resveratrol results in decreased expression of NRIP1 mRNA | CTD | PMID:21109418 |
| troglitazone | decreases expression | EXP | | 6480464 | troglitazone results in decreased expression of NRIP1 mRNA | CTD | PMID:12732648 |
| tunicamycin | increases expression | EXP | | 6480464 | Tunicamycin results in increased expression of NRIP1 mRNA | CTD | PMID:17127020 |
| zearalenone | increases expression | ISO | RGD:1323522 | 6480464 | Zearalenone results in increased expression of NRIP1 mRNA | CTD | PMID:19371625 |